	Therapy monitoring
Malignant glioma
Intracavitary radioimmunotherapy
Serial FET PET
	tumour recurrence
FET uptake
resection cavity
reactive changes
MRI
values
locoregional RIT
recurrence
residual tumour
RIT
tumour-free status
effects
uptake
tumour
high radiation doses
PET
amino acid tracer
patients
threshold
radiation
follow-up
ratios
peak
stable
present study
treatment
Standard treatment
contrast
highest uptake
study
months
FET PET scans
initial surgery
FET
results
radiation therapy
baseline
analysis
purpose
sensitive tool
clinical deterioration
Treatment efficacy
post-therapeutic phase
reliable indicator
normal brain tissue
additional
survival times
blood-brain barrier
criterion

